| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 25 |
| 1 | DEXAMETHASONE 1.5 MG | 25 |
| 2 | BEVACIZUMAB | 18 |
| 3 | PREDNISONE | 17 |
| 4 | CYCLOPHOSPHAMIDE | 16 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 16 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 16 |
| 7 | DOXORUBICIN | 16 |
| 8 | RITUXIMAB | 16 |
| 9 | AMOXICILLIN | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NICARDIPINE HYDROCHLORIDE | 14 | 0.0062 |
| 1 | NICARDIPINE | 15 | 0.0034 |
| 2 | CARMUSTINE | 10 | 0.0021 |
| 3 | FONDAPARINUX SODIUM | 12 | 0.0015 |
| 4 | NIROGACESTAT | 1 | 0.0011 |
| 5 | POLATUZUMAB VEDOTIN | 10 | 0.0010 |
| 6 | METRELEPTIN | 1 | 0.0008 |
| 7 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 11 | 0.0007 |
| 8 | INSULIN GLARGINE-YFGN | 15 | 0.0007 |
| 9 | BENDAMUSTINE HCL | 9 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 32 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 18 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 17 |
| 3 | Alkylating Drug [EPC] | 16 |
| 4 | Insulin Analog [EPC] | 15 |
| 5 | Proton Pump Inhibitor [EPC] | 15 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 14 |
| 7 | Platinum-based Drug [EPC] | 13 |
| 8 | Kinase Inhibitor [EPC] | 11 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 1 | Leptin Analog [EPC] | 1 | 0.0008 |
| 2 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 3 | Topoisomerase Inhibitor [EPC] | 10 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 18 | 0.0001 |
| 5 | BCL-2 Inhibitor [EPC] | 6 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 17 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 13 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 14 | 0.0000 |